Detailed answers about JEEVAN PHARMA LIMITED, including incorporation, status, business activity, and accounts information.
When was JEEVAN PHARMA LIMITED founded?
JEEVAN PHARMA LIMITED was officially incorporated on 17 April 2018 and is registered under company number 11313432. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is JEEVAN PHARMA LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of JEEVAN PHARMA LIMITED?
JEEVAN PHARMA LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does JEEVAN PHARMA LIMITED do?
JEEVAN PHARMA LIMITED operates in the following sector: 47730 - Dispensing chemist in specialised stores. This provides insight into the company's primary business activity and industry focus.
What is JEEVAN PHARMA LIMITED's registered address?
The registered office address of JEEVAN PHARMA LIMITED is ASH PHARMACY, 5 BEAN ROAD, DUDLEY, WEST MIDLANDS, ENGLAND, DY2 8TH. This is the official address filed with Companies House for legal and statutory correspondence.
Is JEEVAN PHARMA LIMITED financially stable?
The most recent accounts for JEEVAN PHARMA LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.
Does JEEVAN PHARMA LIMITED have any charges or mortgages?
JEEVAN PHARMA LIMITED has 3 registered charges, of which 3 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.